Craft

Arch Oncology

Total Funding

$155 M

Arch Oncology Summary

Company Summary

Overview
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. The Company's lead product candidate AO-176 is in Phase 1 clinical trial for the treatment of patients with select solid tumors. In addition, Arch Oncology is advancing pipeline programs, including anti-signal regulatory protein (SIRP) antibodies.
Type
Private
Status
Active
Founded
2006
HQ
Brisbane, CA, US | view all locations
Website
https://www.archoncology.com/
Cybersecurity rating
Sectors

Key People

  • John McKearn, Chairman

    • Daniel Pereira

      Daniel Pereira, Chief Scientific Officer

      • Arun Kashyap

        Arun Kashyap, Vice President, Research

        • Vicki Sung

          Vicki Sung, Vice President, Translational Medicine

          LocationsView all

          2 locations detected

          • Brisbane, CA HQ

            United States

            2000 Sierra Point Pkwy #700Brisbane

          • St. Louis, MO

            United States

            4340 Duncan Ave #301

          Footer menu